Gilla Kaplan, Ph.D.

Gilla Kaplan, Ph.D.

DirectoratTyra Biosciences· In proxies 2023–2025

Gilla Kaplan, Ph.D. sits on 4 public boards.

Boards1

  • Avalo TherapeuticsDirector · 5 yr on the boardIndependentNominating and Corporate Governance—Paid as an executive

Board seats come from each company's latest proxy statement.

Experience

  1. Tyra BiosciencesPublic company · 3 yr
    • Director2023 – Present · 3 yrStock in role +154%
  2. Avalo TherapeuticsPublic company · 3 yr
    • Director2023 – Present · 3 yrNo stock prices for these years
  3. Avalo IncPublic company
    • Director? – PresentNo stock prices for these years
  4. Celgene CorporationPublic company
    • Director? – PresentNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?